Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Multiple Sclerosis Drugs Market Research Reports

Titlepublishedprice

Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2017

By Delve Insight
"...... t including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings......"
01-Jan-2017$1250

Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2017

By Delve Insight
"...... s stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ......"
01-Jan-2017$1250

Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2017

By Delve Insight
"...... rious stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaboratio......"
01-Jan-2017$1250

Multiple Sclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Multiple Sclerosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveI......"
01-Jan-2017$2000

Multiple Sclerosis - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... vers the therapeutics market revenue; average cost of therapy, treatment practice and Multiple Sclerosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemio......"
01-Jan-2017$4950

Rebif -Drug Insights, 2017

By Delve Insight
"...... e Rebif sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Rebif, patents information and exclusivity data, route of synthesis, competitive landscape, and ......"
01-Jan-2017$1000

Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... apsing Multiple Sclerosis (RMS) Report is to understand the market and pipeline status of the drugs around the Relapsing Multiple Sclerosis (RMS) to explore the generic development opportunities, licensing opportunities and to gain competitive advant......"
01-Jan-2017$2000

Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... of the Relapsing Remitting Multiple Sclerosis (RRMS) Report is to understand the market and pipeline status of the drugs around the Relapsing Remitting Multiple Sclerosis (RRMS) to explore the generic development opportunities, licensing opportuniti......"
01-Jan-2017$2000

Tysabri -Drug Insights, 2017

By Delve Insight
"...... des the Tysabri sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Tysabri, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Multiple Sclerosis  - Epidemiology Forecast To 2023

By Delve Insight
"...... prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Multiple Sclerosis . The report is built ......"
01-Jan-2017$2750

Avail upto 50% Discount on below Publisher Reports.